[1]孙莹 姜雅秋.二型脱碘酶泛素化修饰及其基因多态性与甲状腺疾病[J].国际内分泌代谢杂志,2019,39(03):165-167,211.[doi:10.3760/cma.j.issn.1673-4157.2019.03.005]
　Sun Ying,Jiang Yaqiu.Type 2 deiodinase ubiquitination modification and its gene polymorphism and thyroid disease[J].International Journal of Endocrinology and Metabolism,2019,39(03):165-167,211.[doi:10.3760/cma.j.issn.1673-4157.2019.03.005]
点击复制

二型脱碘酶泛素化修饰及其基因多态性与甲状腺疾病()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
39
期数:
2019年03期
页码:
165-167,211
栏目:
综述
出版日期:
2019-05-20

文章信息/Info

Title:
Type 2 deiodinase ubiquitination modification and its gene polymorphism and thyroid disease
作者:
孙莹 姜雅秋
中国医科大学附属第一医院内分泌与代谢病科,中国医科大学内分泌研究所,辽宁省内分泌疾病重点实验室,沈阳 110001
Author(s):
Sun Ying;  Jiang Yaqiu
Department of Endocrinology and Metabolism, The First Hospital of China Medical University, The Endocrine Institute of China Medical University, Key Laboratory of Endocrine Diseases of Liaoning Province, Shenyang 110001, China
关键词:
泛素蛋白酶体通路;  二型脱碘酶;  下丘脑-垂体-甲状腺轴;  泛素化连接酶;  去泛素化酶
Keywords:
Ubiquitin proteasome pathway;  Type 2 deiodozyme;  Hypothalamic-pituitary-thyroid axis;  Ubiquitination ligase;  Deubiquinase
DOI:
10.3760/cma.j.issn.1673-4157.2019.03.005
摘要:
脱碘酶是含硒蛋白酶,包括一型脱碘酶(D1)、二型脱碘酶(D2)和三型脱碘酶(D3),它们在甲状腺激素代谢过程中起重要调节作用。其中D2主要在T4向T3转化、rT3向T2转化过程中起重要作用。D2泛素化过程中涉及两种泛素化连接酶:WSB1、TEB4; 两种去泛素化酶:USP20、USP33。D2对下丘脑-垂体-甲状腺轴调节甲状腺激素的产生过程起重要作用,在甲状腺功能减退症及其治疗中有重要影响,其表达还与甲状腺髓样癌有关。D2泛素化与慢性碘过量致促甲状腺激素水平升高有关。同时,D2基因多态性参与甲状腺激素代谢,影响甲状腺激素水平。
Abstract:
Deiodinase is a selenoproteinase, including type 1 deiodinase(D1), type 2 deiodinase(D2)and type 3 deiodinase(D3), which plays an important regulatory role in the metabolism of thyroid hormone. D2 plays an important role in the transformation from T4 to T3, from rT3 to T2. There are two types of ubiquitination ligases such as WSB1 and TEB4, and two deubiquitination enzymes such as USP20 and USP33, involved in the process of D2 ubiquitination. D2 plays an important role in the regulation of thyroid hormone by hypothalamic-pituitary-thyroid axis(HPT), and plays an important role in hypothyroidism and its treatment. Its expression is also related to medullary thyroid cancer. D2 ubiquitination also involves in the elevation of thyroid stimulating hormone induced by chronic iodine overdose. Meanwhile, D2 gene polymorphism is involved in the metabolism of thyroid hormone and affects the level of thyroid hormone.

参考文献/References:

[1] Finley D,Ulrich HD,Sommer T,et al.The ubiquitin-proteasome system of Saccharomyces cerevisiae[J].Genetics,2012,192(2):319-360.DOI:10.1534/genetics.112.140467.
[2] Sugaya K,Ishihara Y,Inoue S,et al.Characterization of ubiquitin-activating enzyme Uba1 in the nucleus by its mammalian temperature-sensitive mutant[J].PLoS One,2014,9(5):e96666.DOI:10.1371/journal.pone.0096666.
[3] Kinne A,Schülein R,Krause G.Primary and secondary thyroid hormone transporters[J].Thyroid Res,2011,4(Suppl 1):S7.DOI:10.1186/1756-6614-4-S1-S7.
[4] Mullur R,Liu YY,Brent GA.Thyroid hormone regulation of metabolism[J].Physiol Rev,2014,94(2):355-382.DOI:10.1152/physrev.00030.2013.
[5] Harhaj EW,Dixit VM.Deubiquitinases in the regulation of NF-κB signaling[J].Cell Res,2011,21(1):22-39.DOI:10.1038/cr.2010.166.
[6] Werneck de Castro JP,Fonseca TL,Ueta CB,et al.Differences in hypothalamic type 2 deiodinase ubiquitination explain localized sensitivity to thyroxine[J].J Clin Invest,2015,125(2):769-781.DOI:10.1172/JCI77588.
[7] Wouters HJ,van Loon HC,van der Klauw MM,et al.No effect of the Thr92Ala polymorphism of deiodinase-2 on thyroid hormone parameters,health-related quality of life,and cognitive functioning in a large population-based cohort study[J].Thyroid,2017,27(2):147-155.DOI:10.1089/thy.2016.0199.
[8] Ito M,Miyauchi A,Morita S,et al.TSH-suppressive doses of levothyroxine are required to achieve preoperative nativeserum triiodothyronine levels in patients who have undergone total thyroidectomy[J].Eur J Endocrinol,2012,167(3):373-378.DOI:10.1530/EJE-11-1029.
[9] Rosene ML,Wittmann G,Arrojo e Drigo R,et al.Inhibition of the type 2 iodothyronine deiodinase underlies the elevated plasma TSH associated with amiodarone treatment[J].Endocrinology,2010,151(12):5961-5970.DOI:10.1210/en.2010-0553.
[10] Arrojo E Drigo R,Egri P,Jo S,et al. The type Ⅱ deiodinase is retrotranslocated to the cytoplasm and proteasomes viap97/Atx3 complex[J].Mol Endocrinol,2013,27(12):2105-2115.DOI:10.1210/me.2013-1281.
[11] Komander D.Mechanism, specificity and structure of the deubiquitinases[J].Subcell Biochem,2010,54:69-87.DOI:10.1007/978-1-4419-6676-6_6.
[12] Freitas BC,Gereben B,Castillo M,et al.Paracrine signaling by glial cell-derived triiodothyronine activates neuronal gene expression in the rodent brain and human cells[J].J Clin Invest,2010,120(6):2206-2217.DOI:10.1172/JCI41977.
[13] Torlontano M,Durante C,Torrente I,et al.Type 2 deiodinase polymorphism(threonine 92 alanine)predicts L-thyroxine dose to achieve target thyrotropin levels in thyroidectomized patients[J].J Clin Endocrinol Metab,2008,93(3):910-913.
[14] Yang Z,Klionsky DJ.Eaten alive: a history of macroautophagy[J].Nat Cell Biol,2010,12(9):814-822.DOI:10.1038/ncb0910-814.
[15] Meyer EL,Goemann IM,Dora JM,et al.Type 2 iodothyronine deiodinase is highly expressed in medullary thyroid carcinoma[J].Mol Cell Endocrinol,2008,289(1-2):16-22.DOI:10.1016/j.mce.2008.04.009.
[16] Teng W,Shan Z,Teng X,et al.Effect of iodine intake on thyroid diseases in China[J].N Engl J Med,2006,354(26):2783-2793. DOI:10.1056/NEJMoa054022.
[17] Li N,Jiang Y,Shan Z,et al.Prolonged high iodine intake is associated with inhibition of type 2 deiodinase activity in pituitary and elevation of serum thyrotropin levels[J].Br J Nutr,2012,107(5):674-682.DOI:10.1017/S0007114511003552.
[18] Castagna MG,Dentice M,Cantara S,et al.DIO2 Thr92Ala reduces deiodinase-2 activity and serum-T3 levels in thyroid-deficient Patients[J].J Clin Endocrinol Metab,2017,102(5):1623-1630.DOI:10.1210/jc.2016-2587.
[19] Heemstra KA,Hoftijzer H,van der Deure WM,et al.The type 2 deiodinase Thr92Ala polymorphism is associated with increased bone turnover and decreased femoral neck bone mineral density[J].J Bone Miner Res,2010,25(6):1385-1391.DOI:10.1002/jbmr.27.
[20] Al-azzam SI,Alkhateeb AM,Al-Azzeh O,et al.The role of type Ⅱ deiodinase polymorphisms in clinical management of hypothyroid patients treated with levothyroxine[J].Exp Clin Endocrinol Diabetes,2013,121(5):300-305.DOI:10.1055/s-0032-1331695.

备注/Memo

备注/Memo:
通信作者:姜雅秋,Email:Jiangyaqiu@yeah.net
基金项目:国家自然科学基金(81670719)
Corresponding author: Jiang Yaqiu, Email:Jiangyaqiu@yeah.net
Fund program:National Natural Science Foundation of China(81670719)
更新日期/Last Update: 2019-05-20